FDA grants priority review for potential bronchiectasis treatment
BRIDGEWATER, N.J. - Insmed Incorporated (NASDAQ:INSM), a biopharmaceutical company with a market capitalization of $14.57 ...
Sionna Therapeutics, Inc IPOs Tomorrow, Here's What You Need To Know
Sionna Therapeutics, Inc SION IPO will take place February, 07 on the NASDAQ exchange under the ticker SION. The company is ...
toronto.com8 小时
I did the trek of a lifetime in Peru. Not even an invisible disability could stop me
Embarking on this high-altitude adventure, given my severe chronic illness, was challenging but completely worth it ...
imt.ie13 天
Call for children with cystic fibrosis and rare genes to gain access to life-saving therapy
Some people with cystic fibrosis still do not have access to the life-changing modulator therapy drugs, despite wider EMA ...
The Pharma Letter3 小时
FDA Priority Review for Insmed's brensocatib for bronchiectasis
The US Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for brensocatib for patients with ...
The Pharma Letter2 天
Cystic fibrosis company Sionna seeks $150 million raise in IPO
Sionna Therapeutics hopes to raise $150 million and secure a market capitalization of about $692 million in an initial public ...
Independent.ie10 天
‘Time is precious’ – children with rare cystic fibrosis gene denied access to ...
Children whose cystic fibrosis is caused by a rare gene variant are excluded from a new treatment which could potentially ...
Armed robbery in Revesby3 天
Enid's Cystic Fibrosis Clinical Trial Offers Hope
By the time Enid Katz was two years old, she had already suffered through several bouts of bronchitis and was always hungry, ...
Insmed Gets Speedy FDA Review of Brensocatib for Bronchiectasis
The Bridgewater, N.J., biopharmaceutical company said brensocatib has the potential to become the first and only approved treatment for non-cystic fibrosis bronchiectasis, which causes the lungs' ...
Can you get disability benefits for cystic fibrosis? 3 things to do if your claim is denied
If you receive a denial letter from your insurer, don’t appeal the decision before seeking legal advice, says a leading ...
BlackDoctor9 天
When Cystic Fibrosis Hits the Lungs, HIT BACK
When cystic fibrosis hits your lungs hard, hit back. Everything you need to know about getting your lungs back into shape is ...
Vertex Pharmaceuticals' SWOT analysis: biotech giant's stock faces growth challenges
Vertex Pharmaceuticals (NASDAQ:VRTX), a leading biotechnology company known for its cystic fibrosis (CF) treatments, is at a critical juncture as it seeks to diversify its portfolio and maintain its ...